| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Merck Research Laboratories, Department of Genetic and Cellular Toxicology WP45-320, West Point, Pennsylvania 19486
Recently, we have shown a hypermutable response to the food-associated
heterocyclic amine
2-amino-1-methyl-6-phenylimidazo-[4,5-b]-pyridine
(PhIP) in human cells defective in mismatch repair (MMR). These
findings suggest that exogenous compounds such as PhIP may play an
important role in the generation of tumors in MMR-defective
individuals. The specificity of mutations induced by PhIP exposure at
the endogenous HPRT locus was determined in cell lines
defective in MMR to better understand the mutagenic effects of PhIP in
MMR-defective individuals and to gain insight into the molecular
mechanism of carcinogenesis induced by PhIP. Eighty-six induced
HPRT mutants from two different cell lines were isolated
and sequenced after exposure to 10 µM PhIP. Nineteen
(22%) of these mutants contained G:C to T:A transversion mutations,
consistent with the promutagenic adduct of PhIP at the C8 position of
guanine miscoding with adenine. This level of PhIP-induced G:C to T:A
transversions was
4.5-fold higher than spontaneous G:C to T:A
frequencies. Additionally, a hotspot for mutation was observed in a run
of six guanines in HPRT exon 3, where a total of 23
(27%) of all PhIP-induced mutations occurred. These mutations
consisted of transversions, transitions, and frameshift mutations. The
increase in mutant frequency at this run of guanines corresponded to a
24-fold elevation above the spontaneous frequency in one cell line and
a 3.3-fold increase in the other. These data suggest that PhIP may
increase the risk of human carcinogenesis mediated by MMR by increasing
mutations at runs of guanine residues. PhIP may thereby promote
tumorigenesis by mutating growth-regulating genes that contain runs of
guanines in their coding sequences, such as BAX, the
insulin-like growth factor II receptor IGFIIR, and even
the mismatch repair gene hMSH6.
This article has been cited by other articles:
![]() |
S. Creton, H. Zhu, and N. J. Gooderham A Mechanistic Basis for the Role of Cycle Arrest in the Genetic Toxicology of the Dietary Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Toxicol. Sci., April 1, 2005; 84(2): 335 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Andreassen, R. Vikse, I.-L. Steffensen, J. E. Paulsen, and J. Alexander Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc+ allele Mutagenesis, July 1, 2001; 16(4): 309 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bardelli, D. P. Cahill, G. Lederer, M. R. Speicher, K. W. Kinzler, B. Vogelstein, and C. Lengauer Carcinogen-specific induction of genetic instability PNAS, April 5, 2001; (2001) 81082898. [Abstract] [Full Text] |
||||
![]() |
N. Watanabe, E. Okochi, Y. Hirayama, Y. Shimada, K. Yanagihara, M. C. Yoshida, S. Takahashi, M. Mochizuki, T. Sugimura, M. Nagao, et al. Single Nucleotide Instability without Microsatellite Instability in Rat Mammary Carcinomas Cancer Res., March 1, 2001; 61(6): 2632 - 2640. [Abstract] [Full Text] |
||||
![]() |
A. Bardelli, D. P. Cahill, G. Lederer, M. R. Speicher, K. W. Kinzler, B. Vogelstein, and C. Lengauer From the Cover: Carcinogen-specific induction of genetic instability PNAS, May 8, 2001; 98(10): 5770 - 5775. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |